Palm Harbor, FL, United States of America

Oscor Inc.


USPTO Granted Patents = 60

% Expired Patents = 8.3


Trademarks = 5

Forward Citations = 1,688

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Thomas P Osypka (53 out of 59 patents)

silverMedal Timothy Allen Searfoss (9 out of 10 patents)

bronzeMedal Michael J Gelineau (8 out of 8 patents)

4.  Andrew J Enerson (6 out of 8 patents)

5.  Michael Tafone (4 out of 4 patents)

6.  Jeffrey Drum (4 out of 4 patents)

7.  Ronald A Van Den Nieuwenhof (4 out of 4 patents)

8.  Glen Robert Fantuzzi (4 out of 36 patents)

9.  Timothy L Sass (3 out of 3 patents)

10.  Brian Walguarnery (2 out of 2 patents)

11.  Brett Garlock (2 out of 2 patents)

12.  Ernest G DeBella (2 out of 2 patents)

13.  Seth J Worley (2 out of 9 patents)

14.  Mohammed N Islam (2 out of 2 patents)

15.  Jeff Jeffrey Drum (2 out of 2 patents)


Core Competencies:
Vascular Introducer
Steerable Catheter
Implantable Cardiac Lead
Hemostatic Valve
Electrical Connector
Renal Denervation
Deflectable Catheter
Mapping Catheter
Ablation Device
Cuff Lead
Electrode Assembly
Coronary Sinus Lead

60 patents:

Oscor Inc., based in Palm Harbor, Florida, specializes in the development and manufacturing of advanced implantable medical devices. The company focuses on innovative solutions in the fields of vascular access and cardiac care, offering products such as vascular introducers, steerable catheters, and implantable cardiac leads. Oscor is dedicated to enhancing patient outcomes through its cutting-edge technologies, including hemostatic valves and renal denervation systems, while also addressing the evolving needs of healthcare professionals in the medical device sector.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

60 Patents

#1 in Palm Harbor, FL

#135 in Florida

#5,991 in US

#12,077 in the World

Palm Harbor, FL (US)
Palm Harbor, FL, United States of America
Forward Citations = 1,688

26 inventors:

Please report any incorrect information to [email protected]
Loading…